BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 19192140)

  • 21. [Multicentric lymphoma in 411 dogs - an epidemiological study].
    Ernst T; Kessler M; Lautscham E; Willimzig L; Neiger R
    Tierarztl Prax Ausg K Kleintiere Heimtiere; 2016 Aug; 44(4):245-51. PubMed ID: 27111487
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNA ploidy and cell kinetic characteristics in canine non-Hodgkin's lymphoma.
    Teske E; Rutteman GR; Kuipers-Dijkshoorn NJ; van Dierendonck JH; van Heerde P; Cornelisse CJ
    Exp Hematol; 1993 Apr; 21(4):579-84. PubMed ID: 8462667
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of the breed-related glaucomas in pure-bred dogs in North America.
    Gelatt KN; MacKay EO
    Vet Ophthalmol; 2004; 7(2):97-111. PubMed ID: 14982589
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retrospective study on the occurrence of canine lymphoma and associated breed risks in a population of dogs in NSW (2001-2009).
    Yau P; Dhand NK; Thomson PC; Taylor RM
    Aust Vet J; 2017 May; 95(5):149-155. PubMed ID: 28444754
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Study of DNA topoisomerase IIa expression in canine lymphomas and its potential role as a marker of sensitivity to anthracycline-based chemotherapy in dogs.
    Klimiuk P; Lopuszynski W; Bulak K; Smiech A; Brzana A
    Folia Histochem Cytobiol; 2020; 58(1):46-53. PubMed ID: 32176312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical and pathological reassessment of 493 cases of non-Hodgkin's lymphomas according to current WHO classification of lymphoid neoplasms].
    Xiao C; Su ZL; Wu QL; Gao HY; Fang JC; Xia ZJ; Guan ZZ
    Zhonghua Bing Li Xue Za Zhi; 2005 Jan; 34(1):22-7. PubMed ID: 15796877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exome sequencing of lymphomas from three dog breeds reveals somatic mutation patterns reflecting genetic background.
    Elvers I; Turner-Maier J; Swofford R; Koltookian M; Johnson J; Stewart C; Zhang CZ; Schumacher SE; Beroukhim R; Rosenberg M; Thomas R; Mauceli E; Getz G; Palma FD; Modiano JF; Breen M; Lindblad-Toh K; Alföldi J
    Genome Res; 2015 Nov; 25(11):1634-45. PubMed ID: 26377837
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunophenotyping of Non-Hodgkin's lymphomas in Sudan.
    Hamid KH; Elduma AH; Mohamed BM; Salih MM
    Pan Afr Med J; 2014; 18():82. PubMed ID: 25400849
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The animal-dependent risk factors in canine T-cell lymphomas.
    Jankowska U; Jagielski D; Czopowicz M; Sapierzyński R
    Vet Comp Oncol; 2017 Jun; 15(2):307-314. PubMed ID: 26300427
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Breed related odds ratio and anatomic distribution of canine mast cell tumours in Austria. Retrospective study of cases in the years 2000-2010.
    Leidinger EF; Freeman K; Kirtz G; Hooijberg EH; Sick K
    Tierarztl Prax Ausg K Kleintiere Heimtiere; 2014; 42(6):367-73. PubMed ID: 25418504
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disrupted p53 function as predictor of treatment failure and poor prognosis in B- and T-cell non-Hodgkin's lymphoma.
    Møller MB; Gerdes AM; Skjødt K; Mortensen LS; Pedersen NT
    Clin Cancer Res; 1999 May; 5(5):1085-91. PubMed ID: 10353742
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiology and clinical presentation of canine cataracts in France: a retrospective study of 404 cases.
    Donzel E; Arti L; Chahory S
    Vet Ophthalmol; 2017 Mar; 20(2):131-139. PubMed ID: 27061240
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Flow cytometric evaluation of ki67 for the determination of malignancy grade in canine lymphoma.
    Poggi A; Miniscalco B; Morello E; Comazzi S; Gelain ME; Aresu L; Riondato F
    Vet Comp Oncol; 2015 Dec; 13(4):475-80. PubMed ID: 24341365
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Practical aspects of immunocytochemistry in canine lymphomas.
    Sapierzyński R
    Pol J Vet Sci; 2010; 13(4):661-8. PubMed ID: 21370744
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genotype study of non-Hodgkin's lymphoma.
    Pitera R; Pitera JE; Mufti GJ; Salisbury JR
    Pathol Res Pract; 1995 Jun; 191(5):444-55. PubMed ID: 7479363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic significance of morphological subtypes in canine malignant lymphomas during chemotherapy.
    Ponce F; Magnol JP; Ledieu D; Marchal T; Turinelli V; Chalvet-Monfray K; Fournel-Fleury C
    Vet J; 2004 Mar; 167(2):158-66. PubMed ID: 14975390
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of sex, age, and breed for a population of canine leishmaniosis diseased dogs.
    Miranda S; Roura X; Picado A; Ferrer L; Ramis A
    Res Vet Sci; 2008 Aug; 85(1):35-8. PubMed ID: 17942128
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distribution of various subtypes of non-Hodgkin's lymphoma in India: a study of 2773 lymphomas using R.E.A.L. and WHO Classifications.
    Naresh KN; Srinivas V; Soman CS
    Ann Oncol; 2000; 11 Suppl 1():63-7. PubMed ID: 10707782
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunophenotypic classification of canine malignant lymphoma on formalin-mixed paraffin wax-embedded tissue by means of CD3 and CD79a cell markers.
    Milner RJ; Pearson J; Nesbit JW; Close P
    Onderstepoort J Vet Res; 1996 Dec; 63(4):309-13. PubMed ID: 9173362
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nasal and nasal-type natural killer (NK)/T-cell lymphoma: immunophenotype and Epstein-Barr virus (EBV) association.
    Peh SC; Quen QW
    Med J Malaysia; 2003 Jun; 58(2):196-204. PubMed ID: 14569739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.